ロード中...
Inflammatory cytokines and aromatase inhibitor-associated musculoskeletal syndrome: a case–control study
BACKGROUND: The aromatase inhibitor (AI)-associated musculoskeletal syndrome (AIMSS) occurs in approximately 50% of AI-treated patients. Inflammatory mediators are associated with oestrogen signalling and may change with oestrogen depletion. We hypothesised that AIMSS may be associated with changes...
保存先:
| 主要な著者: | , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group
2010
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2920022/ https://ncbi.nlm.nih.gov/pubmed/20606683 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6605768 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|